Trial · NCT00689936
Adverse events2,115
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,115
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | Lenalidomide and Low-Dose Dexamethasone (Rd) | 237 | 532 | |
| other | ANAEMIA | Blood and lymphatic system disorders | Lenalidomide and Dexamethasone (Rd18) | 191 | 540 | |
| other | ANAEMIA | Blood and lymphatic system disorders | Melphalan + Prednisone + Thalidomide (MPT) | 219 | 541 | |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Lenalidomide and Low-Dose Dexamethasone (Rd) | 66 | 532 | |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Lenalidomide and Dexamethasone (Rd18) | 59 | 540 | |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Melphalan + Prednisone + Thalidomide (MPT) | 92 | 541 | |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Lenalidomide and Low-Dose Dexamethasone (Rd) | 60 | 532 | |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Lenalidomide and Dexamethasone (Rd18) | 43 | 540 | |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Melphalan + Prednisone + Thalidomide (MPT) | 71 | 541 | |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Lenalidomide and Low-Dose Dexamethasone (Rd) | 194 | 532 | |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Lenalidomide and Dexamethasone (Rd18) | 177 | 540 | |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Melphalan + Prednisone + Thalidomide (MPT) | 325 | 541 | |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Lenalidomide and Low-Dose Dexamethasone (Rd) | 111 | 532 | |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Lenalidomide and Dexamethasone (Rd18) | 99 | 540 | |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Melphalan + Prednisone + Thalidomide (MPT) | 132 | 541 | |
| other | ATRIAL FIBRILLATION | Cardiac disorders | Lenalidomide and Low-Dose Dexamethasone (Rd) | 30 | 532 | |
| other | ATRIAL FIBRILLATION | Cardiac disorders | Lenalidomide and Dexamethasone (Rd18) | 0 | 540 | |
| other | ATRIAL FIBRILLATION | Cardiac disorders | Melphalan + Prednisone + Thalidomide (MPT) | 0 | 541 | |
| other | VERTIGO | Ear and labyrinth disorders | Lenalidomide and Low-Dose Dexamethasone (Rd) | 27 | 532 | |
| other | VERTIGO | Ear and labyrinth disorders | Lenalidomide and Dexamethasone (Rd18) | 0 | 540 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00689936/events